Promethera Biosciences raised €40M in a Series D+ round in Apr 2019. The company is based in Mont-saint-guibert, Belgium. Investors in the round: Ci:z Investment LLP, ITOCHU Corporation, Korea Investment Partners and 3 others. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €40M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
